Trial Profile
Drug Use-results survey for Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral Solution
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 18 Dec 2014 New trial record